KL
CEROW

KIM LLC’s CERo Therapeutics Warrants CEROW Stock Holding History

KIM LLC’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$1K – 115
2024
Q2 		$1K Hold
50,000
– – ﹤0.01% 237
2024
Q1 		$3.41K Hold
50,000
– – ﹤0.01% 212
2023
Q4 		$1.38K Hold
50,000
– – ﹤0.01% 323
2023
Q3 		$3.58K Hold
50,000
– – ﹤0.01% 363
2023
Q2 		$3.27K Hold
50,000
– – ﹤0.01% 399
2023
Q1 		$2.5K Hold
50,000
– – ﹤0.01% 499
2022
Q4 		$2K Hold
50,000
– – ﹤0.01% 574
2022
Q3 		$7K Hold
50,000
– – ﹤0.01% 671
2022
Q2 		$5K Buy
+50,000
New +$8.06K ﹤0.01% 785

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

KIM LLC's CEROW Position: Q3 2024 in Review

KIM LLC sold out of CERo Therapeutics Warrants (CEROW) in Q3 2024, closing a stake of 50,000 shares — an estimated $1K sold.

KIM LLC first reported a position in CEROW in Q2 2022 and held it in 9 quarters. The position peaked at $7K in Q3 2022. 30 funds tracked by Wall St. Rank hold CEROW as of Q3 2024.

  • KIM LLC reported no remaining CERo Therapeutics Warrants position as of Q3 2024 after selling out during the quarter.
  • KIM LLC sold 50,000 CERo Therapeutics Warrants shares in Q3 2024, an estimated $1K.
  • KIM LLC first reported a position in CERo Therapeutics Warrants in Q2 2022 and held it in 9 quarters.
  • KIM LLC's CERo Therapeutics Warrants position peaked at $7K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q3 2024.

Based on KIM LLC's 13F filing for Q3 2024, filed 13 Nov 2024.